19059464|t|Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
19059464|a|Amyloid beta protein (Abeta) is thought to be responsible for the loss of memory in Alzheimer's disease (AD). A significant decrease in [Arg(8)]-vasopressin (AVP) in the AD brain has been found. However, it is unclear whether the decrease in AVP is involved in Abeta-induced impairment of memory and whether AVP can protect against Abeta-induced neurotoxicity. The present study examines the effects of intracerebroventricular (i.c.v.) injection of AVP on hippocampal long-term potentiation (LTP), a synaptic model of memory, and investigates the potential protective function of AVP in Abeta-induced LTP impairment. The results showed that (1) i.c.v. injection of different concentrations of AVP or Abeta(25-35) did not affect the baseline field excitatory postsynaptic potentials (fEPSPs); (2) AVP administration alone induced a significant increase in HFS-induced LTP, while Abeta(25-35) significantly suppressed HFS-induced LTP; (3) Abeta(25-35)-induced LTP suppression was significantly prevented by the pretreatment with AVP; (4) paired-pulse facilitation did not change after separate application or co-application of AVP and Abeta(25-35). These results indicate that AVP can potentiate hippocampal synaptic plasticity and dose-dependently prevent Abeta(25-35)-induced LTP impairment. Thus, the present study provides further insight into the mechanisms by which Abeta impairs synaptic plasticity and suggests an important approach in the treatment of AD.
19059464	0	8	Arginine	Chemical	MESH:D001120
19059464	99	102	rat	Species	10116
19059464	146	151	Abeta	Gene	54226
19059464	190	204	loss of memory	Disease	MESH:D008569
19059464	208	227	Alzheimer's disease	Disease	MESH:D000544
19059464	229	231	AD	Disease	MESH:D000544
19059464	260	280	[Arg(8)]-vasopressin	Chemical	-
19059464	282	285	AVP	Chemical	MESH:C035362
19059464	294	296	AD	Disease	MESH:D000544
19059464	366	369	AVP	Chemical	MESH:C035362
19059464	385	390	Abeta	Gene	54226
19059464	399	419	impairment of memory	Disease	MESH:D008569
19059464	432	435	AVP	Chemical	MESH:C035362
19059464	456	461	Abeta	Gene	54226
19059464	470	483	neurotoxicity	Disease	MESH:D020258
19059464	573	576	AVP	Chemical	MESH:C035362
19059464	704	707	AVP	Chemical	MESH:C035362
19059464	711	716	Abeta	Gene	54226
19059464	817	820	AVP	Chemical	MESH:C035362
19059464	824	836	Abeta(25-35)	Gene	54226
19059464	920	923	AVP	Chemical	MESH:C035362
19059464	1002	1014	Abeta(25-35)	Gene	54226
19059464	1061	1066	Abeta	Gene	54226
19059464	1151	1154	AVP	Chemical	MESH:C035362
19059464	1249	1252	AVP	Chemical	MESH:C035362
19059464	1257	1269	Abeta(25-35)	Gene	54226
19059464	1299	1302	AVP	Chemical	MESH:C035362
19059464	1379	1391	Abeta(25-35)	Gene	54226
19059464	1494	1499	Abeta	Gene	54226
19059464	1583	1585	AD	Disease	MESH:D000544
19059464	Positive_Correlation	MESH:D008569	54226
19059464	Negative_Correlation	MESH:C035362	MESH:D000544
19059464	Association	MESH:C035362	MESH:D008569
19059464	Positive_Correlation	MESH:D020258	54226
19059464	Association	MESH:C035362	MESH:D020258
19059464	Negative_Correlation	MESH:C035362	54226
19059464	Association	MESH:D000544	54226

